{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:20:07Z","timestamp":1787948407237,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,15]],"date-time":"2016-07-15T00:00:00Z","timestamp":1468540800000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS075527"],"award-info":[{"award-number":["R01NS075527"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH092797"],"award-info":[{"award-number":["MH092797"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","award":["DESC0008432"],"award-info":[{"award-number":["DESC0008432"]}],"id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Applied Radiation and Isotopes"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.apradiso.2015.04.010","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T19:46:19Z","timestamp":1429299979000},"page":"5-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["A practical process for the preparation of [32P]S1P and binding assay for S1P receptor ligands"],"prefix":"10.1016","volume":"102","author":[{"given":"Adam J.","family":"Rosenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhude","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apradiso.2015.04.010_bib1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/cmdc.201000477","article-title":"BZM055, an iodinated radiotracer candidate for PET and SPECT imaging of myelin and FTY720 brain distribution","volume":"6","author":"Briard","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.apradiso.2015.04.010_bib2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.nucmedbio.2006.03.008","article-title":"Discussion of targeting proteins in vivo: in vitro guidelines","volume":"33","author":"Eckelman","year":"2006","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.apradiso.2015.04.010_bib3","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.bmcl.2003.12.099","article-title":"Fluorescence-labeled sphingosines as substrates of sphingosine kinases 1 and 2","volume":"14","author":"Ettmayer","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.apradiso.2015.04.010_bib4","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/sj.bjp.0701926","article-title":"Agonist action at D2(long) dopamine receptors: ligand binding and functional assays","volume":"124","author":"Gardner","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.apradiso.2015.04.010_bib5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0960-894X(02)00999-X","article-title":"Synthesis of fluorescence-labeled sphingosine and sphingosine 1-phosphate; effective tools for sphingosine and sphingosine 1-phosphate behavior","volume":"13","author":"Hakogi","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.apradiso.2015.04.010_bib6","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1021\/jm0492507","article-title":"A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists","volume":"47","author":"Hale","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.apradiso.2015.04.010_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4161\/pri.22650","article-title":"Imaging multiple sclerosis and other neurodegenerative diseases","volume":"7","author":"Inglese","year":"2013","journal-title":"Prion"},{"key":"10.1016\/j.apradiso.2015.04.010_bib8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/01.ATV.0000254679.42583.88","article-title":"The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"27","author":"Keul","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.apradiso.2015.04.010_bib9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1468-1331.2010.03154.x","article-title":"Positron emission tomography imaging in multiple sclerosis\u2013current status and future applications","volume":"18","author":"Kiferle","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.apradiso.2015.04.010_bib10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/1352458512438723","article-title":"FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination","volume":"18","author":"Kipp","year":"2012","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.apradiso.2015.04.010_bib11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bmc.2004.10.008","article-title":"Asymmetric synthesis and biological evaluation of the enantiomeric isomers of the immunosuppressive FTY720-phosphate","volume":"13","author":"Kiuchi","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.apradiso.2015.04.010_bib12","doi-asserted-by":"crossref","first-page":"23722","DOI":"10.1074\/jbc.273.37.23722","article-title":"Molecular cloning and functional characterization of murine sphingosine kinase","volume":"273","author":"Kohama","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.apradiso.2015.04.010_bib13","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrd4099","article-title":"Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond","volume":"12","author":"Kunkel","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.apradiso.2015.04.010_bib14","series-title":"Methods Enzymol","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0076-6879(07)34013-5","article-title":"Measurement of mammalian sphingosine\u20101\u2010phosphate phosphohydrolase activity in vitro and in vivo","author":"Maceyka","year":"2007"},{"key":"10.1016\/j.apradiso.2015.04.010_bib15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.1070238","article-title":"Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists","volume":"296","author":"Mandala","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.apradiso.2015.04.010_bib16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/clpt.2011.349","article-title":"Advances in imaging to support the development of novel therapies for multiple sclerosis","volume":"91","author":"Miller","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.apradiso.2015.04.010_bib17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tips.2013.05.002","article-title":"The structure and function of the S1P1 receptor","volume":"34","author":"O\u2019Sullivan","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.apradiso.2015.04.010_bib18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0006-291X(02)02671-2","article-title":"Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist","volume":"299","author":"Osada","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.apradiso.2015.04.010_bib19","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1016\/j.bmc.2014.08.009","article-title":"Synthesis of fluorinated analogues of sphingosine-1-phosphate antagonists as potential radiotracers for molecular imaging using positron emission tomography","volume":"22","author":"Prasad","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.apradiso.2015.04.010_bib20","series-title":"Sphingosine-1-Phosphate Signaling in Immunology and Infectious Diseases, 2014\/04\/15","first-page":"1","article-title":"The organization of the sphingosine 1-phosphate signaling system","author":"Rosen","year":"2014"},{"key":"10.1016\/j.apradiso.2015.04.010_bib21","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nchembio804","article-title":"Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo","volume":"2","author":"Sanna","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.apradiso.2015.04.010_bib22","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1016\/j.bmc.2013.06.012","article-title":"A sphingosine 1-phosphate receptor 2 selective allosteric agonist","volume":"21","author":"Satsu","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.apradiso.2015.04.010_bib23","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/ATVBAHA.111.241034","article-title":"Sphingosine-1-phosphate receptor 3 promotes neointimal hyperplasia in mouse iliac-femoral arteries","volume":"32","author":"Shimizu","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.apradiso.2015.04.010_bib24","doi-asserted-by":"crossref","first-page":", S9","DOI":"10.1212\/WNL.0b013e31820d9507","article-title":"The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators","volume":"76","author":"Soliven","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.apradiso.2015.04.010_bib25","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1111\/j.1582-4934.2010.01136.x","article-title":"Vascular biology: the role of sphingosine 1-phosphate in both the resting state and inflammation","volume":"14","author":"Swan","year":"2010","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.apradiso.2015.04.010_bib26","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1016\/j.bmcl.2013.09.058","article-title":"Modulators of the sphingosine 1-phosphate receptor 1","volume":"23","author":"Urbano","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.apradiso.2015.04.010_bib28","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0076-6879(00)12925-8","article-title":"Binding of sphingosine 1-phosphate to cell surface receptors","author":"Van Brooklyn","year":"2000"},{"key":"10.1016\/j.apradiso.2015.04.010_bib29","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/glia.21021","article-title":"Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions","volume":"58","author":"Van Doorn","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.apradiso.2015.04.010_bib30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1246\/cl.2008.188","article-title":"Syntheses of fluorescence-labeled sphingosine 1-phosphate methylene and sulfur analogues as possible visible ligands to the receptor","volume":"37","author":"Yamamoto","year":"2008","journal-title":"Chem. Lett."},{"key":"10.1016\/j.apradiso.2015.04.010_bib31","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1002\/ijc.24933","article-title":"Sphingosine-1-phosphate receptor type 1 regulates glioma cell proliferation and correlates with patient survival","volume":"126","author":"Yoshida","year":"2010","journal-title":"Int. J. Cancer"}],"container-title":["Applied Radiation and Isotopes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804315300105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804315300105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:58:48Z","timestamp":1787947128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969804315300105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":30,"alternative-id":["S0969804315300105"],"URL":"https:\/\/doi.org\/10.1016\/j.apradiso.2015.04.010","relation":{},"ISSN":["0969-8043"],"issn-type":[{"value":"0969-8043","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A practical process for the preparation of [32P]S1P and binding assay for S1P receptor ligands","name":"articletitle","label":"Article Title"},{"value":"Applied Radiation and Isotopes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apradiso.2015.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}